|
Rani Therapeutics Holdings Inc (NASDAQ: RANI) |
|
Rani Therapeutics Holdings Inc
RANI's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Rani Therapeutics Holdings Inc growth rates, revenue grew
in the first quarter of 2025 from the same quarter a year ago.
Ranking at No. 2951
Major Pharmaceutical Preparations industry recorded
growth of revenues by 4.44 %
Rani Therapeutics Holdings Inc net loss decreased from $-15 millions, to $-13 millions in first quarter of 2025,
• More on RANI's Growth
|
|
Rani Therapeutics Holdings Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 6.66 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 17.95.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.44.
• More on RANI's Valuation
|
|
|
|
|
Rani Therapeutics Holdings Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 6.66 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 17.95.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.44.
• More on RANI's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com